Please login to the form below

Not currently logged in
Email:
Password:

iniparib

This page shows the latest iniparib news and features for those working in and with pharma, biotech and healthcare.

AZ's Lynparza cleared for ovarian cancer in Europe

AZ's Lynparza cleared for ovarian cancer in Europe

Sanofi was forced to abandon development of its iniparib candidate, which had been in trials for breast and non-small cell lung cancer (NSCLC).

Latest news

More from news
Approximately 1 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics